Moleac.com
  • Home
  • About Us
    • Vision, Values & Mission
    • Milestones
    • Leadership
      • Management Team & Advisors
      • Board of Directors
      • Scientific Advisors & Collaborators
    • Our People, Our Company
    • Responsibility
  • R & D
    • Pipeline
    • Our Strategic Approach
    • Research & Development
    • Publications
  • Products
    • NeuroAiD™II
  • Partners
    • Our Commercial Partners
    • Commercial Partnering Opportunities
    • Research Opportunities
  • News
  • Library
  • Contact Us
  • Career
Select Page
TCM trial for stroke survivors

Mar 8, 2022 | News

Categories

  • News
  • Stroke News

Recent Posts

  • Supporting Stroke Awareness: Moleac at Changi General Hospital’s Inaugural Stroke Matters Day
  • Engaging Discussions at the V National Congress of Neurology in Panama: Highlights from Moleac’s NeuroAiD Symposium
  • World Stroke Day: Moleac’s Commitment to Helping Stroke Patients Reconnect with Their Lives
  • Join the Upcoming ASAP Webinar on Direct Oral Anticoagulants – Supported by Moleac
  • Reflecting on the NeuroAiD Dinner Symposium: Insights into Advancing Neurological Care at WSC 2024 in Abu Dhabi

Quick links

Home
About Us
Contact
Privacy Policy
Terms & Conditions

Find us

Moleac Pte Ltd

Contact

  • Helios #09-08, 11 Biopolis Way, Singapore 138667
  • +65 62113710
  • [email protected]

Identifying the multiple and complex mechanisms of brain damages and repair

Connect

  • Follow
  • Follow
  • Follow
  • Follow

Copyright © 2003-2023. All Rights Reserved. NeuroAiD by Moleac Pte Ltd, Helios #09-08, 11 Biopolis Way, Singapore 138667

loading

Please wait while you are redirected to the right page...